Research Peptide Comparison
Retatrutide Pen 40mg and Tirzepatide 60mg are both GLP-1 Peptides research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
Retatrutide is a synthetic triple agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptors. The simultaneous activation of all three incretin/glucagon pathways places it at the leading edge of metabolic research.
Compared to Tirzepatide 60mg, Retatrutide Pen 40mg is priced at £220.00 with 99%+ verified purity. Its CAS registry number is 2381089-83-2. It has a molecular weight of 4875.42 g/mol.
Retatrutide Pen 40mg is available in 20mg, 40mg and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £55.01 higher than Tirzepatide 60mg.
Tirzepatide is a synthetic peptide that activates both the GLP-1 and GIP receptors, producing simultaneous engagement of the two principal incretin pathways. This combined receptor profile underpins its role in research into glucose homeostasis, weight regulation and pancreatic hormone signalling, and has established it as one of the most-studied dual incretin agonists in modern metabolic research.
Compared to Retatrutide Pen 40mg, Tirzepatide 60mg is priced at £164.99 with 99.5%+ verified purity. Its CAS registry number is 2023788-19-2. It has a molecular weight of 4813.52 g/mol.
Tirzepatide 60mg is available in 15mg, 30mg, 60mg and ships with a full Certificate of Analysis from Janoshik Analytical. At £55.01 less than Retatrutide Pen 40mg, it is the more affordable option in this comparison.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
